RaySearch Laboratories AB (publ) provided preliminary earnings guidance for the third quarter of 2017. Net sales for the third quarter of 2017 are expected to amount to SEK 112 million with operating profit of SEK 1 million and cash flow negative of SEK 1 million. The result has been influenced by three main factors: Weak order intake in Europe, where several major public tenders have been delayed. Continued weakening of the US dollar, where the company’s revenues have decreased as a consequence of a weaker US dollar, which also caused negative translation effects for balance sheet items. Increased costs, where the company so far this year, as a conscious effort, has increased the number of employees in the global market organization and in research and development by about 50%, which has not yet generated increased order intake.